Apollo Hospitals Enterprise shareholding pattern

APOLLOHOSP

6887

61.00 (-0.88%)
Last updated on 2 Feb, 2026 | 12:19 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Apollo Hospitals Enterprise Shareholding Pattern

  • 2018-19
  • 2023-24
  • 2024-25
  • 2022-23
  • 2025-26
  • 2021-22
  • 2020-21
  • 2019-20
  • 2016-17
Total Promoters
Segment
Percent

Total Promoters

29.33%

Mutual Fund

6.64%

Insurance

5.49%

Foreign Institutional Investors

52.41%

Domestic Institutional Investors

0.27%

Retail

5.8%

Others

0.06%

Total Promoters
MAR '21
29.82%
JUN '21
29.82%
SEP '21
29.82%
DEC '21
29.33%

Summary

For Year 2025-26, Apollo Hospitals Enterprise reports the following shareholding: Total Promoters at 28.02%, Mutual Fund at 16.75%, Insurance at 3.64%, Foreign Institutional Investors at 43.54%, Domestic Institutional Investors at 1.35%, and Retail at 6.71%. This breakdown provides a quick snapshot of ownership distribution for Apollo Hospitals Enterprise in 2025-26.

Apollo Hospitals Enterprise FAQs

As of 02-2026, the promoter shareholding in Apollo Hospitals Enterprise stands at 28.02% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Apollo Hospitals Enterprise is 43.54% and 1.35% respectively.

The retail shareholding of the Apollo Hospitals Enterprise is 6.71%.

Changes in shareholding patterns of Apollo Hospitals Enterprise can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Apollo Hospitals Enterprise are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.